 | |
 | |
| Company type | Public |
|---|---|
| ISIN | IE00BTN1Y115 |
| Industry | Medical equipment |
| Founded | 1949 |
| Headquarters | |
Key people | |
| Products | Medical devices |
| Revenue |  US$32.36 billion (2024) |
 US$5.144 billion (2024) | |
| US$3.676 billion (2024) | |
| Total assets | US$89.98 billion (2024) |
| Total equity | US$50.21 billion (2024) |
Number of employees | c. 95,000 (2024) |
| Website | medtronic.com |
| Footnotes / references Financials as of April 26, 2024[update].[2] | |
Medtronic plc is an American-Irish medical device company. The company's operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015.[3][4] While it primarily operates in the United States,[5][6] it operates in more than 150 countries and employs over 90,000 people.[7] It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue.
- ^ a b "Locations". medtronic.com.
- ^ "Medtronic Plc FY 2024 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. 20 June 2024.
- ^ "Medtronic to buy Covidien for $42.9 billion, rebase in Ireland". Reuters. 16 June 2014.
U.S. medical device maker Medtronic Inc (MDT.N) said on Sunday it had agreed to buy Covidien Plc COV.N for $42.9 billion in cash and stock and move its executive base to Ireland in the latest transaction aiming for lower corporate tax rates abroad.
- ^ Reilly, Mark (16 June 2014). "Medtronic will buy Covidien for $42.9 billion; HQ goes to Ireland, CEO stays here". www.bizjournals.com. Retrieved 25 October 2022.
- ^ Monique Ellis (30 May 2018). "The top 10 medical device companies". Proclinical.
Medtronic is the top medical device company in the world for 2018 with an impressive annual revenue nearly $30 billion in 2017. The company experienced a 3% increase in revenue compared with 2016 figures and they reported 'balanced, diversified growth across all groups and regions'. Revenue increases are also due in part to the consolidation of its acquisition of Covidien.
- ^ Jonathan D. Rockoff; Nina Trentmann (11 February 2018). "New Tax Law Haunts Inversion Deals". Wall Street Journal.
- ^ Yu, Jea (27 July 2022). "Medtronic Stock Keeps Ticking Forward". Entrepreneur. Retrieved 19 October 2022.